Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling: Erratum
| dc.contributor.author | Sun, Xun | |
| dc.contributor.author | Li, Kexin | |
| dc.contributor.author | Hase, Misato | |
| dc.contributor.author | Zha, Rongrong | |
| dc.contributor.author | Feng, Yan | |
| dc.contributor.author | Li, Bai-Yan | |
| dc.contributor.author | Yokota, Hiroki | |
| dc.contributor.department | Biomedical Engineering, School of Engineering and Technology | |
| dc.date.accessioned | 2023-10-18T13:28:40Z | |
| dc.date.available | 2023-10-18T13:28:40Z | |
| dc.date.issued | 2023-01-01 | |
| dc.description.abstract | [This corrects the article DOI: 10.7150/thno.66148.]. | |
| dc.eprint.version | Final published version | |
| dc.identifier.citation | Sun X, Li K, Hase M, et al. Erratum: Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling: Erratum. Theranostics. 2023;13(1):16-19. Published 2023 Jan 1. doi:10.7150/thno.79085 | |
| dc.identifier.uri | https://hdl.handle.net/1805/36437 | |
| dc.language.iso | en_US | |
| dc.publisher | Ivyspring International | |
| dc.relation.isversionof | 10.7150/thno.79085 | |
| dc.relation.journal | Theranostics | |
| dc.rights | Attribution 4.0 International | en |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.source | PMC | |
| dc.subject | Breast cancer | |
| dc.subject | Osteoblasts | |
| dc.subject | Hsp90ab1 | |
| dc.subject | Moesin | |
| dc.subject | CD44 | |
| dc.title | Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling: Erratum | |
| dc.type | Article |